Photene progresses in UKRI Funded program

Feb 25, 2024

In February, team Photene from the University of Nottingham successfully pitched to the UKRI ICURe Explore panel. The feedback we received was very positive, and as a result we have now progressed onto the next stage of the programme – ICURe Exploit.

ICURe (Innovation to Commercialisation of University Research) is a UKRI funded program, which allows scientists to explore the potential market opportunity of their University research. Over the last 4 months, Team Photene has spoken to over 100 different institutions, from industry & academia, to find out how Carbene Footprinting might be used within industry. Throughout the process, we have had brilliant feedback and real interest from industry, which continues to need new and improved techniques to map binding sites.

Congratulations to the Photene Team – Neil Oldham, Joe Dawson, Martin Whitaker and Harry Taylor for their success. Our thanks as well to the ICURe Team (Cath Whitaker, Kevin Marks and Selina Forsythe) for all their support to get to this next exciting stage

If you’d like to hear more about what excited the ICURe panel about our binding site analysis technology, and the benefits for your drug discovery and lead optimisation programmes, then please get in touch!

If you’d like to hear more about Carbene Footprinting, then please click here. 

#ProteinFootprinting #BindingSiteAnalysis #EpitopeMapping #DrugDiscovery #DrugDevelopment #Pharmaceutical #Proteomics #Biotherapeutics #MolecularGlues #PROTAC #AntibodyDiscovery #Antibodies